Molecular Partners AG (MOLN)
3.60
-0.47
(-11.55%)
USD |
NASDAQ |
May 31, 16:00
Molecular Partners Cash and Short Term Investments (Quarterly): 192.99M for March 31, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 192.99M |
| December 31, 2023 | 222.50M |
| September 30, 2023 | 225.83M |
| June 30, 2023 | 242.64M |
| March 31, 2023 | 254.38M |
| December 31, 2022 | 268.72M |
| September 30, 2022 | 273.94M |
| June 30, 2022 | 298.70M |
| March 31, 2022 | 320.87M |
| December 31, 2021 | 145.29M |
| September 30, 2021 | 165.07M |
| June 30, 2021 | 189.21M |
| December 31, 2020 | 198.84M |
| June 30, 2020 | 67.72M |
| December 31, 2019 | 98.13M |
| Date | Value |
|---|---|
| June 30, 2019 | 126.17M |
| June 30, 2019 | 126.17M |
| December 31, 2018 | 100.51M |
| June 30, 2018 | 122.65M |
| June 30, 2018 | 122.65M |
| December 31, 2017 | 144.81M |
| June 30, 2017 | 164.15M |
| June 30, 2017 | 164.15M |
| December 31, 2016 | 177.12M |
| June 30, 2016 | 200.41M |
| June 30, 2016 | 200.41M |
| December 31, 2015 | 217.91M |
| June 30, 2015 | 189.61M |
| June 30, 2015 | 189.61M |
| December 31, 2014 | 190.51M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
67.72M
Minimum
Jun 2020
320.87M
Maximum
Mar 2022
201.01M
Average
198.84M
Median
Dec 2020
Cash and Short Term Investments (Quarterly) Benchmarks
| AC Immune SA | 116.17M |
| CRISPR Therapeutics AG | 2.108B |
| Addex Therapeutics Ltd | 4.603M |
| NLS Pharmaceutics Ltd | 0.8977M |
| MoonLake Immunotherapeutics | 547.05M |